Attached files

file filename
EX-99.01 - EXHIBIT 99.01 - Inspyr Therapeutics, Inc.v398416_ex99-01.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): January 8, 2015

 

 

 

GENSPERA, INC.

(Exact name of registrant as specified in Charter)

 

Delaware   0001421204   20-0438951

(State or other jurisdiction of

incorporation or organization)

  (Commission File No.)   (IRS Employee Identification No.)

 

2511 N Loop 1604 W, Suite 204

San Antonio, TX 78258

(Address of Principal Executive Offices)

 

210-479-8112

(Issuer Telephone number)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 

 

 
 

 

Item 8.01Other Events.

 

On January 8, 2015, GenSpera, Inc. announced that it will maintain a collection of online corporate communication channels to provide on-going direct communication with shareholders and other interested parties. A copy of the press release is attached to this report as Exhibit 99.01.

 

Investors and others should note that the Company announces material, non-public information regarding GenSpera using the company website (www.genspera.com), its investor relations website, SEC filings, press releases, public conference calls and webcasts. Information about Genspera, its business, and its results of operations may also be announced by posts on the following social media channels:

 

Facebook: https://www.facebook.com/GenSpera

 

Twitter: https://twitter.com/GenSperaNews

 

LinkedIn: https://www.linkedin.com/company/genspera-inc-

 

Google+: https://plus.google.com/u/0/b/111021404725787491742/111021404725787491742/posts

 

YouTube: https://www.youtube.com/channel/UCdvATHFsc6ZLVgVMTJtPq3A

 

The Chairman’s Blog: http://www.thechairmansblog.com/genspera

 

The information we post through these social media channels may be deemed material. Accordingly, investors should monitor these accounts and the blog, in addition to following the company’s press releases, SEC filings and public conference calls and webcasts. This list may be updated from time to time.

 

Item 9.01.Financial Statements and Exhibits.

 

Exhibit

No.

 

  

Description

99.01   Press Release dated January 8, 2015

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: January 8, 2015

 

GenSpera, Inc.
     
By:   /s/ Craig Dionne
   

Craig Dionne

Chief Executive Officer


 

 
 

 

INDEX OF EXHIBITS

 

Exhibit

No.

 

  

Description

99.01   Press Release dated January 8, 2015